| GENE_SYMBOL |
HGNC_ID |
UNIPROT_ID |
DRUG_NAME |
PUBCHEM_CID |
Datasource |
| ACVR1 |
HGNC:171 |
Q04771 |
7-fluoro-6-methoxy-4-[6-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]-4aH-quinolin-2-one |
168430302 |
BindingDB |
| ACVR1 |
HGNC:171 |
Q04771 |
(S)-(1-(2-((5-phenyl-1H-pyrazol-3-yl)amino)furo[3,2-d]pyrimidin-4-yl)pyrrolidin-2-yl)methanol |
168430351 |
BindingDB |
| ACVR1 |
HGNC:171 |
Q04771 |
((2S,2'S)-1,1'-(4-((1-(3,4,5-trimethoxyphenyl)-1H-imidazol-4-yl)amino)quinazoline-2,7-diyl)bis(pyrrolidine-2,1-diyl))dimethanol |
168430352 |
BindingDB |
| ACVR1 |
HGNC:171 |
Q04771 |
US20230303562, Example 11 |
169074396 |
BindingDB |
| ACVR1B |
HGNC:172 |
P36896 |
Imatinib |
5291 |
BindingDB |
| ACVR1B |
HGNC:172 |
P36896 |
Gefitinib |
123631 |
BindingDB |
| ACVR1B |
HGNC:172 |
P36896 |
Vatalanib |
151194 |
BindingDB |
| ACVR1B |
HGNC:172 |
P36896 |
Ruboxistaurin |
153999 |
BindingDB |
| ACVR1B |
HGNC:172 |
P36896 |
Canertinib |
156414 |
BindingDB |
| ACVR1B |
HGNC:172 |
P36896 |
Doramapimod |
156422 |
BindingDB |
| ACVR1B |
HGNC:172 |
P36896 |
Seliciclib |
160355 |
BindingDB |
| ACVR1B |
HGNC:172 |
P36896 |
Enzastaurin |
176167 |
BindingDB |
| ACVR1B |
HGNC:172 |
P36896 |
Erlotinib |
176870 |
BindingDB |
| ACVR1B |
HGNC:172 |
P36896 |
Lapatinib |
208908 |
BindingDB |
| ACVR1B |
HGNC:172 |
P36896 |
Sorafenib |
216239 |
BindingDB |
| ACVR1B |
HGNC:172 |
P36896 |
Nilotinib |
644241 |
BindingDB |
| ACVR1B |
HGNC:172 |
P36896 |
(5Z)-2-(3-methylphenyl)-5-{[3-(4-methylphenyl)-1-phenyl-1H-pyrazol-4-yl]methylidene}[1,3]thiazolo[3,2-b][1,2,4]triazol-6(5H)-one |
1989136 |
BindingDB |
| ACVR1B |
HGNC:172 |
P36896 |
N-(5-(((5-(1,1-Dimethylethyl)-2-oxazolyl)methyl)thio)-2-thiazolyl)-4-piperidinecarboxamide |
3025986 |
BindingDB |
| ACVR1B |
HGNC:172 |
P36896 |
Tandutinib |
3038522 |
BindingDB |
| ACVR1B |
HGNC:172 |
P36896 |
Neflamapimod |
3038525 |
BindingDB |